West Pharmaceutical Services | WST - Bénéfice Avant Impôts

Prix De L'Action
314.38
Variation Quotidienne
4.41 1.42%
Mensuellement
21.22%
Annuel
47.49%
Q2 Prévisions
294.43




Bénéfice Avant Impôts Changement Date
Align Technology USD 148.89M 27.71M 2026-03
Avanos Medical USD 1.2M 2.4M 2025-12
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Cerus USD -20.76M 17.9M 2024-12
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cooper Companies USD 116.8M 137.4M 2025-09
Dentsply International USD -147M 83M 2025-12
Haemonetics USD 59.97M 8.69M 2025-12
ICU Medical USD 70.3M 36.62M 2025-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD 4.31M 11.13M 2025-12
IQVIA Holdings USD 6.22B 5.68B 2026-03
J&J USD 7.82B 2.86B 2026-03
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Neogen USD 28M 15.81M 2025-09
OraSure Technologies USD -18.43M 5.14M 2025-12
Quidel USD -79.5M 32.9M 2026-03
Repligen USD 19.11M 2M 2025-12
Rockwell Medical USD 343K 2.07M 2024-06
Solventum Corp USD 332M 179M 2025-12
STAAR Surgical USD 18.79M 44.7M 2025-09
Terumo JPY 45.38B 578M 2025-12
Utah Medical Products 418K 3K 2024-09
West Pharmaceutical Services USD 161.5M 8.6M 2025-12